| Description |
1 online resource |
| Contents |
Front Cover -- Front Matter -- SEMISYNTHESIS OF BIOACTIVE COMPOUNDS AND THEIR BIOLOGICAL ACTIVITIES -- Copyright -- Contents -- One -- Preliminary concept of semisynthesis and its importance -- 1.1 Introduction -- 1.1.1 Concept of semisynthesis -- 1.1.2 Why do we need semisynthesis? -- 1.1.3 Recent advances in the potential applications of semisynthetic derivatives -- 1.1.4 Relationship between semisynthesis and drug delivery -- References -- Two -- Semisynthesis of antibiotics -- 2.1 Current antibiotic resistance mechanism -- 2.2 Chemical derivatization of antibiotics |
|
2.2.1 Semisynthesis of platencin thioether derivatives -- 2.2.2 Semisynthesis of dialkylresorcinol derivatives -- 2.2.3 Semisynthesis of unguinol derivatives -- 2.2.4 Semisynthesis of arsinothricin -- 2.2.5 Semisynthesis of fidaxomicin derivatives -- 2.2.6 Semisynthesis of amidochelocardin derivatives -- 2.2.7 Semisynthesis of nidulin derivatives -- 2.2.8 Semisynthesis of teicoplanin derivatives -- 2.2.9 Semisynthesis of platensimycin derivatives -- 2.2.10 Semisynthesis of glycopeptides -- 2.2.11 Semisynthesis of lipopeptides -- 2.2.12 Semisynthesis of caprazene derivatives |
|
2.3 Recent advances in the clinical applications of antibiotics and their analogs -- References -- Three -- Semisynthesis of alkaloids -- 3.1 Function of plant alkaloids on human health -- 3.1.1 Anticancer activity of plant alkaloids -- 3.1.2 Antimicrobial activity of plant alkaloids -- 3.2 Semisynthetic modification of alkaloids -- 3.2.1 Semisynthesis of apetalrine B -- 3.2.2 Semisynthesis of promising derivatives of the verticillin class of natural products -- 3.2.3 Semisynthesis of promising derivatives of rutaecarpine and evodiamine |
|
3.2.4 Semisynthesis of (+)- and (−)-spondomine and stereoisomers -- 3.2.5 Semisynthesis of esters of galanthamine, 3-O-methylpancracine, vittatine, and maritidine -- 3.2.6 Semisynthesis of brevicanines A and B -- 3.2.7 Semisynthesis of 15-chloro-18-oximinoether derivatives -- 3.2.8 Semisynthesis of 2-epi-narciclasine -- 3.2.9 Semisynthesis of acetylated makaluvamines -- 3.2.10 Semisynthesis of the analogs of maclekarpine E -- 3.2.11 Semisynthesis of (+)-goniomitine -- 3.2.12 Semisynthesis of piperine-based hydrazone derivatives -- 3.2.13 Semisynthesis of lipo-alkaloids |
|
3.2.14 Semisynthesis of oxystemofoline, methoxystemofoline and analogs -- 3.3 Semisynthesis of bioactive marine alkaloids -- 3.3.1 Semisynthesis of N12-acetylpseudoceratidine, N12-formylpseudoceratidine, N-methylpseudoceratidine and pseudoceratidine azid ... -- 3.3.2 Semisynthesis of antitumor drug Ecteinascidin 743 and (−)-Jorumycin -- 3.3.3 Semisynthesis of monoamines derivative -- 3.3.4 Semisynthesis of discorhabdins P and U and analogs of discorhabdin C -- 3.4 Recent progress in semisynthesis and potential applications of semisynthetic alkaloid derivatives -- References |
|
Four -- Semisynthesis of flavones |
| Subject |
Bioactive compounds -- Synthesis.
|
|
Bioactive compounds -- Physiological effect.
|
|
Composés bioactifs -- Synthèse.
|
|
Composés bioactifs -- Effets physiologiques.
|
| Added Author |
Manickam, Sivakumar.
|
| Other Form: |
Print version: 9780443152702 |
|
Print version: 0443152691 9780443152696 (OCoLC)1349273554 |
| ISBN |
9780443152702 (electronic bk.) |
|
0443152705 (electronic bk.) |
|
9780443152696 |
|
0443152691 |
| Standard No. |
AU@ 000076053458 |
|
